HLA class I and class II antigens associated with multiple myeloma in southern Africa

被引:11
|
作者
Patel, M
Wadee, AA
Galpin, J
Gavalakis, C
Fourie, AM
Kuschke, RH
Philip, V
机构
[1] Chris Hani Baragwanath Hosp, Dept Med, Haematol Unit, Johannesburg, South Africa
[2] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[3] S African Inst Med Res, Dept Immunol, ZA-2000 Johannesburg, South Africa
[4] S African Inst Med Res, Dept Haematol, ZA-2000 Johannesburg, South Africa
[5] Univ Witwatersrand, Dept Actuarial Sci, Johannesburg, South Africa
来源
CLINICAL AND LABORATORY HAEMATOLOGY | 2002年 / 24卷 / 04期
关键词
aetiology; blacks; genetic factors; HLA associations; multiple myeloma; South Africa;
D O I
10.1046/j.1365-2257.2002.00448.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
While the exact aetiology of myeloma is unknown, genetic factors feature among the potential risk factors. The HLA phenotypes in African blacks with myeloma (the commonest haematopoietic malignancy in this group) have not been characterized. The purpose of this study was to determine the HLA class I and class II phenotypes of patients with multiple myeloma and to compare the findings to an ethnically matched control group of 100 individuals. Analysis of the HLA class I and class II phenotypes in 62 myeloma patients revealed: (i) a corresponding statistically significant association with HLA B18 [odds ratio (OR) 6.3; 95% confidence interval (CI) 1.013-39.727; P < 0.005]; (ii) no statistically significant association with HLA B13, Cw2, Cw6 or the DR and DQ antigens; and (iii) a statistically significant negative (protective) association with HLA Cw7 (OR 0.4; 95% CI 0.21-0.87; P < 0.005). This study suggests that although genetic factors may play a role in the multifactorial aetiology of multiple myeloma, with the exception of HLA B18, there is no specific association between HLA types and multiple myeloma in South African blacks.
引用
下载
收藏
页码:215 / 219
页数:5
相关论文
共 50 条
  • [1] The association of HLA class I antigens and class II alleles with multiple myeloma in Turkey.
    Kalayoglu-Besisik, S
    Erer, B
    Savran-Oguz, F
    Yucel, S
    Erten, N
    Yenerel, M
    Sargin, D
    BLOOD, 2003, 102 (11) : 374B - 375B
  • [2] HLA class I and class II antigen frequencies in multiple myeloma
    Alcoceba, M.
    Marin, L. A.
    Balanzategui, A.
    Martin-Jimenez, P.
    Sarasquete, M. E.
    Chillon, C.
    Corral, R.
    Garcia-Sanz, R.
    Gonzalez, M.
    TISSUE ANTIGENS, 2007, 69 (05): : 454 - 454
  • [3] Soluble HLA class I and class II antigens in patients with multiple sclerosis
    Ott, M
    Seidl, C
    Westhoff, U
    Stecker, K
    Seifried, E
    Fischer, PA
    Grosse-Wilde, H
    TISSUE ANTIGENS, 1998, 51 (03): : 301 - 304
  • [4] HLA class I and class II antigens in sarcoidosis
    Morar, R.
    Duarte, R.
    Wadee, A. A.
    Feldman, C.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (12): : 904 - 910
  • [5] STRUCTURE OF CLASS-I AND CLASS-II HLA ANTIGENS
    STROMINGER, JL
    BRITISH MEDICAL BULLETIN, 1987, 43 (01) : 81 - 93
  • [6] The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
    Sayad, Arezou
    Akbari, Mohammad Taghi
    Mehdizadeh, Mahshid
    Roshandel, Elham
    Abedinpour, Soheila
    Hajifathali, Abbas
    TURKISH JOURNAL OF HEMATOLOGY, 2014, 31 (04) : 388 - 393
  • [7] HLA class II disease associations in southern Africa
    Lombard, Z
    Brune, AE
    Hoal, EG
    Babb, C
    Van Helden, PD
    Epplen, JT
    Bornman, L
    TISSUE ANTIGENS, 2006, 67 (02): : 97 - 110
  • [8] Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population
    Tastan, HB
    Akar, A
    Orkunoglu, FE
    Arca, E
    Inal, A
    PIGMENT CELL RESEARCH, 2004, 17 (02): : 181 - 184
  • [9] EPITOPES OF HLA CLASS I AND CLASS II ANTIGENS AND THEIR RELEVANCE FOR KIDNEY ALLOTRANSPLANTATION
    Sutta, Adrian
    Roder, Matej
    Slavcev, Antonij
    HLA, 2021, 97 (04) : 319 - 319
  • [10] Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease
    Fogdell-Hahn, A
    Ligers, A
    Gronning, M
    Hillert, J
    Olerup, O
    TISSUE ANTIGENS, 2000, 55 (02): : 140 - 148